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Background: Penicillin is recommended as the ﬁrst-line agent
for intrapartum antibiotic prophylaxis, while ampicillin is con-
sidered as an acceptable alternative. Although GBS strains are
generally susceptible to penicillin with only occasional resistance,
they show varying resistance to erythromycin, clindamycin and
tetracycline. Therefore, a knowledge of the resistance proﬁle of GBS
in the local environmentwill be useful for administration of appro-
priateintrapartumantibiotics prophylaxis.
Methods & Materials: Rectovaginal swabs collected from
pregnant women were cultured for GBS using conventional
media.Kirby-Bauer disc diffusion method was performed accord-
ing to the Clinical Laboratory Standards Institute (CLSI) guidelines
on GBS isolates to determine the antibiotic susceptibility pat-
terns of the isolates. Inducible clindamycin resistancewas detected
by using the D-zone test. Resistance determinants were dis-
cerned with conventional PCR. Streptococcus agalactiae control
strainsIa (2008232728),Ib (2008232729),III (2008232582) andV
(2008232731) from CDC were usedfor quality control of antibiotic
susceptibility testing.
Results: All 46 available strains of GBS colonizing the pregnant
mothers were uniformly susceptible (100%) to penicillin, van-
comycin and ceftriaxone, while 44 (95.7%) and 41 (89.1%) were
resistant to tetracycline and trimethoprim- sulfamethoxazole
respectively (Table 2). Only three (6.5%) of the isolates showed
erythromycin-clindamycin inducible resistance. ermA gene was
present in all three GBS isolates with erythromycin-clindamycin
inducible resistance and absent in the only one strain with inter-
mediate resistance. ermB was absent in all the four strains tested
while the mefA/E gene was carried by two of the macrolide- clin-
damycin resistance isolates. tetM gene was carried by all isolates
that showed tetracycline resistance phenotypes.
Antibiotic Susceptibility Proﬁle of maternal GBS Strains
Antibiotic Susceptibility, % Intermediate
susceptibility, %
Resistance, %
Penicillin G (10U) 46 (100) - -
Erythromycin (15ug) 43 (93.5) - 3 (6.5)
Clindamycin (2ug) 42 (91.2) 1 (2.3) 3 (6.5)
Vancomycin (30ug) 46 (100) - -
Tetracycline (30ug) 2 (4.3) - 44 (95.7)
Ceftraixone (30ug) 46 (100) - -
Ciproﬂoxaxin (5ug) 46 (100) - -
SXT (1.25/23.75ug) 5 (10.9) - 41 (89.1)
SXT: Trimethoprim- Sulfamethoxazole
(n =46)
Conclusion: In this study, all GBS isolates were susceptible to
PenicillinG, the recommended antibiotic for intrapartumantibiotic
prophylaxis. Also, a very low resistance rate recorded for erythro-
mycin and clindamycin in this study implied that women allergic
to -lactam antibiotics can alternatively receive intravenous clin-
damycin or erythromycin.
http://dx.doi.org/10.1016/j.ijid.2014.03.1138
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Background: Biologic therapies for rheumatologic diseases,
which are targeted at molecules involved in the mechanisms
of the immune system, provide an alternative to the existing
treatment methods of disease-modifying anti-rheumatic drugs
and other immunosuppressive medications. Biologic agents have
demonstrated efﬁcacy in inﬂammatory rheumatic diseases (IRDs).
However, the drugs have side effects, inparticular increased risk of
bacterial and viral infection.
Methods & Materials: 705 patients with rheumatic diseases
who received biologics treatment evaluated for the presence of
active infection by clinical examination, blood count, urine anal-
ysis, liver function tests, chest X-ray, HbsAg, Anti-HCV, tuberculin
skin test and bacterial and tuberculosis culture study if necessary.
Results: Patients (Ankylosing Spondylitis (AS):329; Entero-
pathic Arthritis (EA):64; Psoriatic Arthritis (PSA):44; Rheumatoid
Arthritis (RA):175; Behcet’s Disease (BD):34; Familial Mediter-
renean Fever (FMF):21; Juvenile Rheumatoid Arthritis (JRA):10;
Others:26) were identiﬁed by reviewing the medical records
treated with biologic agents; abatacept (2%); adalimumab (33%),
inﬂiximab (24.4%), golimumab (2.6%), rituximab (10.7%), anakinra
(1.7%), canacinumab (0.1%), tocilizumab (1%) or etanercept (24.3%)
between 2003 and 2012. Mean disease duration was 9.95±7.73
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years (0.5-50)andmeandrug treatmentdurationwas19.78±16.05
months (1-108). Therewere 4 common infections pnömonia (2.1%;
AS:5; EPA:1; PSA:2; RA:5; BD:1; JRA:1), urinary infection (2.7%;
AS:8; EPA:2; RA:7; JRA:1), urinary tract tuberculosis (0.7%; AS:1;
RA:4) and herpes zoster (0.7%; AS:2; EPA:1; RA:1; Others:1) in
all patients. HbsAg was positive in patients who received adali-
mumab (n=1), etanercept (n =1), rituximab (n=2). Anti-HCV was
positive in patients who received adalimumab (n=1), etanercept
(n =2), inﬂiximab (n=2). Urinary tract tuberculosis was present in
5 patients (AS:1; RA:4)who received abatacept (n =1), adalimumab
(n=1), etanercept (n =2), rituximab (n=1).Noviral infectionactiva-
tionwas seen inpatientswithHbsAgandAnti-HCVpositive.Herpes
zoster was present in 5 patients (AS:2; EPA:1; RA:1; Others:1) who
received adalimumab (n=3), inﬂiximab (n=1), rituximab (n=1).
Conclusion: Our results suggest thatbiologic therapies for
rheumatologic diseases have demonstrated rare infections such as
pnömonia, urinary infection, urinary tract tuberculosis and herpes
zoster. Biologic treatments appears to be safety although long time
follow up.
http://dx.doi.org/10.1016/j.ijid.2014.03.1139
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Background: Porphyromonas gingivalis, a major periodontal
pathogen, is gaining increasing attention for its possible association
with atherosclerosis. Its ﬁmbriae are classiﬁed into six genotypes
(Types I-V, Ib) based 0on the diversity of the ﬁm A genes encoding
the ﬁmbrial subunits. In this study, ﬁm A genotype’s distribution of
P. gingivalis was analyzed in atherosclerotic plaque specimens.
Methods & Materials: A total of 50 atherosclerotic plaque
specimens and 50 non-atherosclerotic, post stenotic aneurysm
specimens were collected from patients undergoing cardiovascu-
lar surgery. Bacterial DNA was also extracted from each specimen,
as real-time PCR was carried out with P. gingivalis-speciﬁc primer
sets. The positive specimens of P. gingivalis were further analyzed
to discriminate the ﬁm A genotype using real-time and nested PCR
methods.
Results: P. gingivalis was detected only in one atherosclerotic
plaque; however, the genotype was nontypable in this specimen.
Conclusion: We state that it is not easy to show a signiﬁ-
cant relationship between P. gingivalis, its ﬁm A genotype, and
atherosclerosis.We suggest that new extended studies based espe-
cially upon the quantitave determination of P. gingivalis and its
genotype distribution on atherosclerotic specimens are needed to
show an evident relationship between atherosclerosis and P. gin-
givalis.
http://dx.doi.org/10.1016/j.ijid.2014.03.1140
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Tuberculin skin test and QuantiFERON test for
detection of latent Mycobacterium tuberculosis
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Kasr el-Aini, Cairo, Egypt
Background: Not everyone infected with Mycobacterium
Tuberculosis bacteria (MTB) becomes sick. As a result, two TB-
related conditions exist: latent TB infection and TB disease. Persons
with latent TB infection do not feel sick and do not have any symp-
toms. They are infected with M. tuberculosis, but do not have TB
disease. Overall, without treatment, about 5 to 10% of infected per-
sons will develop TB disease at some time in their lives. About half
of those peoplewho develop TBwill do sowithin the ﬁrst two years
of infection.
Methods & Materials: Our aim in this study was to determine
the prevalence of latent M. tuberculosis using tuberculin skin test-
ing (TST) and QuantiFERON- TB Gold In- Tube (QFT- GIT) test in
household contacts with pulmonary TB.
Results: A total of 88 participants had both a TST result and
a QFT-GIT test results available for comparison. QFT- GIT showed
lower positive results than TST (39.8% vs. %76.1.) We found poor
agreementbetween the two tests (kappa=0.014)). Eight caseswere
negative for TST and positive for QFT- GIT. No statistical signiﬁcant
relation was found between BCG vaccination or age with the result
of TST and QFT- GIT whether positive or negative
Conclusion: TST had higher results than QFT- GIT in determin-
ing latent M. tuberculosis in household contacts with pulmonary
TB. Discordant results between TST and QTF- GIT were common
in our study, so further studies are needed to get a better under-
standing of this phenomenon,which is of high practical importance
when QFT- GIT results will be used for therapeutic decisionmaking
http://dx.doi.org/10.1016/j.ijid.2014.03.1141
